Seminars in Arthritis and Rheumatism

Article	Citations
Corrigendum to “Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice” [Seminars in Arthritis and Rheumatism 71 (2025) 152640]	115
A clue for subclinical CNO in adolescents with acne conglobata and hidradenitis suppurativa: Persistan acute phase rectans elevation	84
Refining RA-ILD screening: Diagnostic limitations and the emerging role of lung ultrasound	79
Risk prediction models for incident systemic lupus erythematosus among women in the Nurses’ health study cohorts using genetics, family history, and lifestyle and environmental factors	75
Performance of cut-offs of the ASAS Health Index to discriminate between treatment groups in patients with axial spondyloarthritis in the TICOSPA trial	75
Combotherapies in immune-mediated inflammatory diseases: A study using the Clinical Data Warehouse from Paris Hospitals’ Public Assistance	73
Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritis	59
Hydroxyquinone use does not increase the risk of venous thromboembolism in rheumatoid arthritis patients—Real-world evidence from a population-based cohort study	56
Immunotherapy in cancer	43
Letter to the editor regarding Outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: A meta-analysis and systematic review	43
Response letter to the editor	43
The Autoantibody response in rheumatoid arthritis; what makes it unique?	41
Survival of adults with rheumatoid arthritis associated interstitial lung disease - A systematic review and meta-analysis	38
Looking at Fibromyalgia differently – the meaning and consequences of fibromyalgia as a dimensional disorder	38
Response to the correspondence by Xu et al. regarding "Toward a more actionable RA-ILD risk model"	37
Expanding the role of mycophenolic acid in pediatric lupus nephritis: A holistic approach to extrarenal findings, side effects, and long-term outcomes	37
Is mixed connective tissue disease (MCTD) a subtype of systemic sclerosis?	36
Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort	36
Interstitial lung disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis: chest CT patterns and correlation with survival	34
Quantification of coronary artery calcification in systemic sclerosis using visual ordinal and deep learning scoring: Association with systemic sclerosis clinical features	34
mRNA vaccines in the rheumatologist's future	33
Immunogenicity of Rituximab biosimilar GP2013 in chronic inflammatory rheumatic disorders in daily clinical practice	33
OMERACT validation of a deep learning algorithm for automated absolute quantification of knee joint effusion versus manual semi-quantitative assessment	32
OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments	32
Update on IgG4-related periaortitis/retroperitoneal fibrosis and periarteritis -recent clinical, diagnostic and therapeutic advances	32

Disease characteristics, co-morbidities and treatment response in a contemporary axial spondyloarthritis cohort: Analysis of 717 patients from the Greek AxSpA registry	31
Almost half of the patients with axial spondyloarthritis reporting an acceptable symptom state have high disease activity; data from two standard-of-care cohorts	31
Sodium-glucose cotransporter 2 (SGLT2) inhibition and autoimmunity	29
Are there causal mucosal drivers in the preclinical development of rheumatoid arthritis?	28
Prevalence of crystal deposits in asymptomatic hyperuricemia according to different scanning definitions: A comparative study	28
A cohort study on the associations between age at natural menopause and rheumatoid arthritis in postmenopausal women from the Canadian Longitudinal Study on Aging	27
Corrigendum to “The Glucocorticoid Toxicity Index: Measuring Change in Glucocorticoid Toxicity Over Time” [Seminars in Arthritis and Rheumatism 55 (2022):152010]	27
Response to: Comment to “Vitamin D in psoriatic arthritis—A systematic review and meta-analysis”	26
Interstitial lung disease phenotype in mixed, differentiated, or overlapping, connective tissue diseases: Comment on the article by Boleto et al.	25
Raynaud's phenomenon secondary to central nervous system stimulants: A therapeutic role of α-1 adrenergic blockers?	25
Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritis	25
Response letter to the Editor	25
Assessing domain match and feasibility of candidate instruments matching with OMERACT endorsed domains to measure flare in knee and hip osteoarthritis	25
A population-based analysis of rheumatology care patterns for inflammatory arthritis during COVID-19 in Alberta, Canada	25
AA amyloidosis in inflammatory joint diseases: A systematic review	25
Longitudinal changes on cranial magnetic resonance imaging in relapsing giant cell arteritis	24
Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial	24
Outcomes of respiratory syncytial virus infection in patients with systemic autoimmune rheumatic disease	23
Imaging to predict early relapses after treatment discontinuation in patients with large vessel giant cell arteritis – A cohort study	23
The clinical features of juvenile dermatomyositis: A single-centre inception cohort	23
Psychological stress in rheumatoid arthritis: a systematic scoping review	22
Is there room for precocious prevention in rheumatoid arthritis precision medicine? A temporal and stratified reframing in diagnostic and therapeutic pathway	22
The state of the Osteoarthritis Initiative (OAI): Entering a new era	22
Using patient reported outcomes measurement information system (PROMIS®) measures in rheumatoid arthritis clinical care, research, and trials	22
Methotrexate treatment in hand osteoarthritis refractory to usual treatments: A randomised, double-blind, placebo-controlled trial	21
Giant cell arteritis associated with scalp, tongue or lip necrosis: A French multicenter case control study	21
Hematopoietic stem cell transplant, chimeric antigen receptor T-cells, and other cellular therapies as stepping stones toward long-term improvement in severe scleroderma and other autoimmune diseases	21
A randomized controlled trial evaluating the effects of social networking on chronic disease management in rheumatoid arthritis	21
Targeting the Wnt pathway for the treatment of Osteoarthritis of the knee	21
Women with Rheumatoid Arthritis have similar rates of postpartum maternal outcomes compared to women without autoimmune disease	20
Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofaciti	20
Response to commentary on IgG4-related uveitis. A French cohort and literature review	20
The Role of Myositis-Specific Autoantibodies and the Management of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: A Systematic Review	20
Is there a role for Pneumocystis jiroveci pneumonia prophylaxis in giant cell arteritis or polymyalgia rheumatica?	20
Effect of zoledronic acid with or without methylprednisolone on 3D bone area and bone shape in patients with symptomatic knee osteoarthritis: A post-hoc analysis of the ZAP2 trial	20
Response: Early referral of patients with suspected polymyalgia rheumatica: An active involvement of the out-of-hospital public rheumatologist is needed. Reply letter to Ciro Manzo (letter to the edit	20
The autoimmune rheumatological presentation of Common Variable Immunodeficiency Disorders with an overview of genetic testing	19
Mechanisms of joint pain: Five short lessons from osteoarthritis	19
Improvement of bone mineral density and new vertebral fractures during 8 years of TNF-α inhibition in patients with axial spondyloarthritis	19
Looking at fibromyalgia differently – An observational study of the meaning and consequences of fibromyalgia as a dimensional disorder	19
Discriminating capacity of the ASAS health index in patients with axial spondyloarthritis treated with ixekizumab	19
Standardizing health outcomes for people with rheumatoid arthritis receiving disease modifying drug therapy: A rapid review of patient-decision aids and preference studies to inform the development of	19
Defining a personalized treatment approach to rheumatoid arthritis: Using genetic markers of TNFi response	19
Further expanding the clinical spectrum of giant cell arteritis: Non-classical organ involvement and uncommon complications	19
HRCT imaging of pulmonary involvement in granulomatosis with polyangiitis and microscopic polyangiitis at disease onset and during follow-up	18
The control group matters: Pain, physical function and strength improvements relative to the comparator intervention in knee and hip osteoarthritis	18
Pathogenesis and targets in uveitis	17
Multiple morbidities are associated with serious infections in patients with rheumatoid arthritis	17
Systematic review of colchicine neuromyopathy: Risk factors, duration and resolution	17
Risk factors for invasive fungal infections in patients with connective tissue disease: Systematic review and meta-analysis	17

Therapeutic approach to central nervous system involvement of Behçet's disease	17
CAR T-cell therapy in SLE: A systematic review	17
Molecular mechanisms underlying thrombosis in systemic lupus erythematosus – A Systematic review	17
Effects of exercise-based interventions on inflammatory markers in patients with fibromyalgia: A systematic review and meta-analysis	17
Causal association of diet-derived circulating antioxidants with the risk of rheumatoid arthritis: A Mendelian randomization study	17
Real-world persistence of urate-lowering therapy following a treat-to-target intervention: A two-year follow-up analysis of the STOP gout trial	16
Response to Letter to the Editor regarding "Nailfold Capillaroscopy as a Predictor of Cardiovascular Events and Mortality in Systemic Sclerosis"	16
Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients	16
Analytical performance of commercial myositis-specific autoantibody tests evaluated against immunoprecipitation assays as a reference standard: A systematic review and meta-analysis	16
Sarcoidosis incidence after mTOR inhibitor treatment	16
The role of sex and systemic inflammation in the development of cardiovascular disease in osteoarthritis: A population-based cohort study using the CLSA	16
Juvenile and adult-onset scleroderma: Different clinical phenotypes	15
Synovial fibroblasts in juvenile idiopathic arthritis: A scoping review	15
Male rheumatoid arthritis patients at substantially higher risk for cardiovascular mortality in comparison to women	15
Effects of neuromuscular control and strengthening exercises on MRI-measured thigh tissue composition and muscle properties in people with knee osteoarthritis – an exploratory secondary analysis from	15
Prognostic factors in giant cell arteritis associated aortitis with PET/CT and CT angiography at diagnosis	15
Comment on: Miedany et al. Beyond the symptoms: Personalizing giant cell arteritis care through multidimensional patient reported outcome measure	15
Advances in Targeted Therapies (ATT) What's cooking in the academic's kitchen? 3TR (IMI)	15
Phenotype of diffuse cutaneous systemic sclerosis patients with positive anticentromere antibodies: A systematic literature review and meta-analysis	15
Central sensitization has major impact on quality of life in patients with axial spondyloarthritis	15
Association between Kawasaki disease and subsequent autoimmune disease: National cohort study of adolescents with 12-year follow-up from birth	14
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group	14
Autoinflammatory syndromes with coexisting variants in Mediterranean FeVer and other genes: Utility of multiple gene screening and the possible impact of gene dosage	14
Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world da	14
Factors associated with cardiovascular events in systemic lupus erythematosus in a monocentric cohort with up to 40 years of follow-up	14
Autonomic dysfunction symptoms in Sjögren’s Disease: A missed dimension linked to disease burden and work disability	14
Comments on the article by Goldman et al.	14
Response to: ‘Critical Commentary ‘Infectious complications of Belimumab with standard care in systemic lupus erythematosus: A systematic review and meta-analysis’ by Saketh Sainag Mandiga et al	14
Table of Contents	14
Comparison between rheumatoid arthritis with malignant lymphoma and other malignancies: Analysis of a National Database of Rheumatic Disease in Japan	14
COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis	14
Biologics in peripheral ulcerative keratitis	14
Modelling long-term outcomes for patients with systemic lupus erythematosus	14
Predicting anxiety and depression in systemic lupus erythematosus: the role of inflammation, sociodemographic variables and clinical factors	14
Reply on: International, multidisciplinary Delphi consensus recommendations on non-pharmacological interventions for fibromyalgia	14
Co-occurrence of giant cell arteritis in patients with polymyalgia rheumatica. Comment on the article by Nielsen AW, et al	14
Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets	13
Efficacy, safety, and cost-effectiveness of therapeutic drug monitoring (TDM) for TNF inhibitor therapy in rheumatic disease: A systematic review and meta-analysis	13
Unraveling the role of neutrophil extracellular traps in rheumatoid arthritis: From triggers to therapeutic targets	13
Defining patient perception of overall well-being and disease activity in the OMERACT Juvenile Idiopathic Arthritis (JIA) core domain set: A report from the JIA working group	13
Subclinical coronary artery calcification in systemic sclerosis using high-resolution chest CT: Identification, extent, and disease-specific risk factors	13
Autoimmune rheumatic disease in Australian Aboriginal and Torres Strait Islander Peoples: What do we know?	13
Preventive effect of beta-blockers in the development of aortic dilation in giant cell arteritis-related aortitis	13
Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review	13
Rheumatoid arthritis and the risk of 90-day readmission after hospitalization for heart failure	13
Acknowledgement of Referees	13
Cognitive impairment and other neuropsychiatric manifestations in patients with primary vasculitis: a systematic review	13
An analysis of the first relapse in giant cell arteritis using ultrasonography	13
Response to the letter entitled " Letter to the editor to Soluble CXCL16 is a prognostic biomarker associated with rapidly progressive interstitial lung disease complicated with dermatomyositis" by Ga	13
The shrinking toe sign in gout	13
Methotrexate use reduces mortality risk in rheumatoid arthritis: A systematic review and meta-analysis of cohort studies	13
Historical bioarcheological aspects of diffuse idiopathic skeletal hyperostosis in humans	13
Efficacy and safety of anti-Tumor Necrosis Factor-α biosimilars in Juvenile Idiopathic Arthritis - a systematic review and meta-analysis	13
Developing efficient predictive models for the diagnosis of VEXAS syndrome	13
Does the time to the onset of lupus nephritis impact renal disease presentation and outcomes?	12
Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus	12
Psychometric properties of patient-reported outcomes measurement information system (PROMIS) fixed short forms in Juvenile Myositis	12
How is early spondyloarthritis defined in the literature? Results from a systematic review	12
Comparative analysis of disease outcomes: Early vs. late transition from psoriasis to psoriatic arthritis	12
Immunosuppressive therapy to treat newly diagnosed primary heart involvement in patients with systemic sclerosis: An Italian cardiac magnetic resonance based study	12
The natural history of end-stage knee osteoarthritis: Data from the osteoarthritis initiative	12
Incidence and prevalence of systemic sclerosis in Sweden, 2004–2015, a register-based study	12
Self-esteem, self-concept, and body image of young people with rheumatic and musculoskeletal diseases: A systematic literature review	12
Risk of new onset of immune-mediated diseases after SARS-CoV-2 infection: A systematic review and meta-analysis	12
Remission in gout is possible: 5-year follow-up in the NOR-Gout study	12
Aortic disease in giant cell arteritis	12
Predicting best treatment in rheumatoid arthritis	12
Algorithmic approaches in hand imaging for rheumatic musculoskeletal diseases: A systematic literature review	12
Minimally invasive interventional procedures for osteoarthritis and inflammatory arthritis: A systematic review and meta-analysis	12
Giant cell arteritis-related stroke in a large inception cohort: A comparative study	12
Characteristics and long-term outcomes of patients with rheumatoid arthritis and concurrent calcium pyrophosphate deposition disease	12
Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice	12
Assessment of triple antiphospholipid antibody-positive patients based on clinical and laboratory domains of 2023 ACR/EULAR antiphospholipid syndrome classification criteria	11
Efficacy and safety of pharmacological treatments for autoimmune disease-associated interstitial lung disease: A systematic review and network meta-analysis	11
Prevalence of frailty and prefrailty in systemic lupus erythematosus: A systematic review and meta-analysis	11
Critical commentary: Factors associated with thrombosis in Behçet syndrome: A systematic review and meta-analysis	11
Age of onset of rheumatoid arthritis and radiographic changes	11
Diffuse generalized venulitis as the primary pathology of Behçet's disease: A comprehensive magnetic resonance venography study	11
Does body mass index mediate the relationship between socioeconomic position and incident osteoarthritis?	11
The prognostic power of anti-topoisomerase I and anti-centromere antibodies in systemic sclerosis - A systematic review of the literature	11

Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials	11
Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options	11
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set	11
Giant cell arteritis – New treatment targets at the horizon	11
A prospective observational cohort study and systematic review of 40 patients with mouth and genital ulcers with inflamed cartilage (MAGIC) syndrome	11
Risk of incident gout following exposure to recombinant zoster vaccine in US adults aged ≥65 years	11
Treatment strategies and outcomes in adult relapsing or refractory cutaneous IgA Vasculitis: A multicenter retrospective cohort study	11
Impact of previous glucocorticoid therapy on diagnostic accuracy of [18F] FDG PET-CT in giant cell arteritis	11
Outcomes in ANCA-associated vasculitis patients with end-stage kidney disease on renal replacement therapy—A meta-analysis	11
Severity and mortality of COVID-19 in patients with systemic sclerosis: a Brazilian multicenter study	11
Variations in Takayasu arteritis characteristics in a cohort of patients with different racial backgrounds	10
Correspondence on “Allopurinol adherence, persistence and patterns of use in individuals with diabetes and gout: A retrospective, population-based cohort analysis” by Weisman et al.	10
SAPHO syndrome: Patient stratification and the new horizon of precision medicine	10
Racial differences in persistent glucocorticoid use patterns among medicaid beneficiaries with incident systemic lupus erythematosus	10
Telemedicine in rheumatology care: A systematic review	10
[18F]Sodium Fluoride PET has the potential to identify active formation of calcinosis cutis in limited cutaneous systemic sclerosis	10
COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study	10
Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working group	10
Impact of biologics on health-related quality of life in patients with Ankylosing spondylitis: A systematic review and meta-analysis of randomized controlled trials	10
Definitions of rheumatoid arthritis flare and how they relate to patients’ perspectives: A scoping review of qualitative and quantitative evidence	10
Diffuse idiopathic skeletal hyperostosis (DISH) and trabecular bone score (TBS) in postmenopausal women: The Camargo cohort	10
Clinical association of health-related quality of life and mortality in an antineutrophil cytoplasmic antibody-associated vasculitis cohort	10
Taper versus discontinuation of tocilizumab in patients with giant cell arteritis: Real-world experience from a tertiary center	10
Determining the Best Discriminatory Physical Functioning Outcome Measurement Instrument for Psoriatic Arthritis Trials: A Meta-Epidemiological Study	10
Sodium-glucose cotransporter 1 inhibition and gout: Mendelian randomisation study	9
Patients’ perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working Group	9
Sleep disorders in rheumatoid arthritis: Incidence, risk factors and association with dementia	9
Measurement properties of the decisional conflict scale in people living with chronic non-cancer pain: a secondary analysis of the DECIDE-PAIN pan-Canadian survey	9
Evolution of bone lesions in adults with chronic nonbacterial osteitis (CNO): A long-term follow-up study	9
Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies	9
Comparing Raynaud’s phenomenon attack measurement tools: paper or smartphone application?	9
Effects of cumulative lifetime estrogen exposure on the clinical characteristics and courses in postmenopausal women with rheumatoid arthritis	9
Identifying domains for CNO and SAPHO: A scoping review to create domains from existing outcomes by the OMERACT CNO and SAPHO working group	9
The immune pathology of bursitis in rheumatic inflammatory diseases, degenerative conditions and mechanical stress: A systematic review	9
Trends in adverse pregnancy outcomes among women with systemic sclerosis in the United States	9
Early-onset juvenile dermatomyositis: A tertiary referral center experience and review of the literature	9
Prevalence and risk factors of antinuclear antibodies among pregnant women: A cross-sectional study in Qingdao, China	9
Effectiveness and safety of anti-CD20 monoclonal antibodies versus csDMARDs in anti-Jo-1 antisynthetase syndrome: A retrospective cohort study	9
Neuropathic pain in spondyloarthritis: Decoding its prevalence, risk factors, and impact on disease activity	9
Reply to: Expanding the role of mycophenolic acid in pediatric lupus nephritis: A holistic approach to extrarenal findings, side effects, and long-term outcomes	9
Macrophages–Autoimmunity–Treatment option	9
Validation studies of rheumatoid arthritis patient-reported outcome measures in populations at risk for inequity: A systematic review and analysis using the OMERACT summary of measurement properties e	9
Author Reply to Letter to the Editor	8
Reply on: a meta-analysis of clinical manifestations in asian systemic lupus erythematous: The effects of ancestry, ethnicity and gender	8
Referees	8
Traditional laboratory parameters and IFNγ-related biomarkers in the diagnosis and management of MAS	8
Disease activity at conception predicts lupus flare up to two years after birth: A multicentre long term follow-up study	8
Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023	8
Comprehensive analysis of disease activity, neuropsychiatric symptoms, imaging features and risk factors for seizure in hospitalized patients with juvenile-onset neuropsychiatric systemic lupus erythe	8
Healthy dietary pattern and risk of rheumatoid arthritis: A systematic review and meta-analysis	8
Navigating the path of progress: The OMERACT 2023 emerging leaders program	8
Development of a prediction model for poor prognosis in childhood-onset Takayasu's arteritis	8
Raynaud’s phenomenon is associated with an increased risk of cardiovascular disease and venous thromboembolism	8
CNO/SAPHO: is it time for new serological biomarkers?	8
Why most (but perhaps not all) DMARDs work equally well	8
Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)	8
Effect modification by contextual factors of urate-lowering therapy on serum urate in people with gout: A systematic review with meta-regression analysis	8
Systematic review of imaging tests to predict the development of rheumatoid arthritis in people with unclassified arthritis	8
Role of intravenous immunoglobulins in systemic sclerosis (SSc): A systematic literature review	8
Risk of major adverse cardiovascular events following targeted therapy in patients with rheumatoid arthritis: a real-world analysis stratified by cardiovascular risk	8
Joint and muscle inflammatory disease: A scoping review of the published evidence	8
Adipocytokines and achievement of low disease activity in rheumatoid arthritis	8
The use of ASDAS to evaluate disease activity and response to treatment in patients with axial spondyloarthritis starting the first biological drug: Are ASAS recommendations being followed?	8
Scoping literature review to identify candidate domains for the OMERACT Systemic Lupus Erythematosus core outcome set	8
Ultra-high frequency ultrasound for digital arteries: improving the characterization of vasculopathy in systemic sclerosis	8
Serum ferritin as a significant biomarker for patients with idiopathic inflammatory myopathy-associated interstitial lung disease: A systematic review and meta-analysis	8
Bone and entheseal targets for growth factors in diffuse idiopathic skeletal hyperostosis	8
Does smoking protect against developing osteoarthritis? Evidence from a genetically informed perspective	8
Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group	8
Immune checkpoint inhibitors and rheumatoid arthritis: All roads lead to PD-1?	8
Corrigendum to The Glucocorticoid Toxicity Index: Measuring Change in Glucocorticoid Toxicity Over Time [Seminars in Arthritis and Rheumatism Volume 55, 152010]	8
Polygenic risk scores	8
Brain white matter microstructural alterations in Behcet's syndrome correlate with cognitive impairment and disease severity: A diffusion tensor imaging study	8
Come rain or shine: Is weather a risk factor for musculoskeletal pain? A systematic review with meta-analysis of case-crossover studies	8
Evaluation of a measure of end-stage knee osteoarthritis compared to total knee replacement: An observational study using multicohort data	7
Predictors of remission in people with axial spondyloarthritis: A systematic literature review	7
Corrigendum to “Clinical characterization, long-term follow-up, and response to treatment of patients with syndrome of undifferentiated recurrent fever (SURF)” Seminars in Arthritis and Rheumatism 55	7
Characteristics Of Difficult-To-Treat Psoriatic Arthritis: A Comparative Analysis	7
One-year survival benefit of plasma exchange in idiopathic inflammatory myositis patients with progressive interstitial lung disease-a systemic review and meta-analysis	7
Investigating the disparities among drug categories in drug-induced dermatomyositis: A systematic review	7
Summary of findings tables for measurement property reviews: The evolution and application of OMERACT's summary of measurement properties (SOMP) Table.	7
Role of F-18 FDG-PET CT scan in the evaluation of medium vessel vasculitis	7
Correspondence on “Methotrexate treatment in hand osteoarthritis refractory to usual treatments: A randomised, double-blind, placebo-controlled trial” by Ferrero et al	7
Commentary on: “Prevalence of frailty and prefrailty in systemic lupus erythematosus: A systematic review and meta-analysis”	7
Menopausal hormone therapy and risk of seropositive rheumatoid arthritis: A nationwide cohort study in Korea	7
An updated systematic review and meta-analysis of randomised controlled trials on the effects of urate-lowering therapy initiation during a gout flare	7
Core domain set for studies of acute calcium pyrophosphate crystal arthritis: OMERACT delphi survey to establish consensus	7
Cognitive impairment in the immune-mediated inflammatory diseases compared with age-matched controls: Systematic review and meta-regression	7
Development and evaluation of shared decision-making tools in rheumatology: A scoping review	7
Anti-HMGCR myopathy: Diversity of clinical presentations in a national cohort in New Zealand	7
Response to Dr. Wolfe	7
Baseline serum biomarkers of inflammation, bone turnover and adipokines predict spinal radiographic progression in ankylosing spondylitis patients on TNF inhibitor therapy	7
Trends in avascular necrosis and related arthroplasties in hospitalized patients with systemic lupus erythematosus and rheumatoid arthritis	7
Assessing the quality of forced vital capacity measurement in patients with systemic sclerosis	7
Effectiveness and tolerability of antifibrotics in rheumatoid arthritis-associated interstitial lung disease	7